Correction to: Phase I-II trial of imatinib mesylate (Gleevec; STI571) in treatment of recurrent oligodendroglioma and mixed oligoastrocytoma. North central cancer treatment group study N0272 (ALLIANCE/NCCTG).

Jaeckle, Kurt A; Anderson, S K; Twohy, Erin L; Dixon, Jesse G; Giannini, Caterina; Jenkins, Robert; Egorin, Merrill J; Sarkaria, Jann N; Brown, Paul D; Flynn, P J; Schwerkoske, John; Buckner, Jan C; Galanis, Evanthia

Jaeckle, Kurt A; Anderson, S K; Twohy, Erin L; Dixon, Jesse G; Giannini, Caterina; Jenkins, Robert; Egorin, Merrill J; Sarkaria, Jann N; Brown, Paul D; Flynn, P J; Schwerkoske, John; Buckner, Jan C; Galanis, Evanthia.

Afiliação

Jaeckle KA; Mayo Clinic Florida, 4500 San Pablo Road, Jacksonville, FL, 32224, USA. jaeckle.kurt@mayo.edu.
Anderson SK; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
Twohy EL; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
Dixon JG; Alliance Statistics and Data Center, Mayo Clinic, Rochester, MN, USA.
Giannini C; Mayo Clinic Rochester, Rochester, MN, USA.
Jenkins R; Mayo Clinic Rochester, Rochester, MN, USA.
Egorin MJ; University of Pittsburgh, Pittsburgh, PA, USA.
Sarkaria JN; Mayo Clinic Rochester, Rochester, MN, USA.
Brown PD; Mayo Clinic Rochester, Rochester, MN, USA.
Flynn PJ; , Metro-Minnesota, St. Louis Park, MN, USA.
Schwerkoske J; , Metro-Minnesota, St. Louis Park, MN, USA.
Buckner JC; Mayo Clinic Rochester, Rochester, MN, USA.
Galanis E; Mayo Clinic Rochester, Rochester, MN, USA.

J Neurooncol ; 143(3): 583, 2019 Jul.

Article em En | MEDLINE | ID: mdl-31165953

ABSTRACT

ABSTRACT

The last author's first name was truncated in the initial online publication. The original article has been corrected.

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Neurooncol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google